Depletion of B cell‐activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Obesity-induced adipose-tissue dysfunction is a critical contributor to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). B cell-activating factor (BAFF) is an adipokine related to impaired insulin sensitivity, and the serum BAFF concentration is associated with NAFLD severity. In this study, we aimed to determine the direct in vivo role of BAFF in the development of insulin resistance, adipocyte dysfunction, and hepatic steatosis using BAFF −/− mice fed a high-fat diet (HFD). HFD-fed BAFF −/− mice exhibited significantly improved insulin sensitivity despite their increased weight gain and adiposity relative to HFD-fed wild-type mice. Moreover, inflammation, especially the accumulation of CD11c + adipose-tissue macrophages, and fibrosis of epididymal adipose tissue were reduced, contributing to healthy adipose-tissue expansion in obese BAFF −/− mice. In line with metabolically healthy obesity, hepatic steatosis also decreased, and we observed attenuated de novo lipogenesis in both the livers and hepatocytes of BAFF −/− mice. Our data revealed that BAFF serves as a potential stimulator of unhealthy adipose-tissue expansion by triggering inflammation and fibrosis and ultimately leading to enhanced insulin resistance and NAFLD. Therefore, these results suggest that BAFF is a promising target for diabetes and NAFLD treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Lipid distribution in adipose tissue and liver is altered in BAFF−/− mice fed an HFD. (A) Changes in body weight of BAFF−/− and WT mice fed an ND or HFD (n = 25–55/group). (B) Organ weight [(organ weight/body weight) × 100%] in BAFF−/− and WT mice fed an ND (n = 6/group) or HFD (n = 7/group) for 24 weeks. For all bar plots shown, data are expressed as the mean ± SD, and significance was determined by two-tailed Student’s t test (A) and Mann–Whitney U test (B). ♯♯♯P < 0.001 compared to WT-ND mice. *P < 0.05, **P < 0.01, and ***P < 0.001 compared to WT-HFD mice. BAFF, B cell-activating factor; WT, wild-type; ND, normal diet; HFD, high-fat diet; SAT, subcutaneous adipose tissue; EAT, epididymal adipose tissue; RpAT, retroperitoneal adipose tissue; VAT, visceral adipose tissue; BAT, brown adipose tissue.](https://figures.cochat.ai/paper-figures/fe4c782630c34c72bd738501928cccbf/depletion-of-b-cellactivating-factor-attenuates-hepatic-fat-accumulation-in-a-figure-1.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Despite increased weight gain and adiposity, BAFF‐deficient mice fed an HFD have improved insulin sensitivity, decreased adipose tissue inflammation, and reduced hepatic steatosis in an adipokine‐like role.( 62 )”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Adipose tissue remodeling and obesity
Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI
Khan, T., Muise, E. S., Iyengar, P., Wang, Z. V., Chandalia, M., Abate, N., Zhang, B. B., Bonaldo, P., Chua, S., & Scherer, P. E. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01300-08 · Cited by 1,053
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013
Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications
Strissel, K. J., Stancheva, Z., Miyoshi, H., Perfield, J. W., DeFuria, J., Jick, Z., Greenberg, A. S., & Obin, M. S. (2007) · Diabetes · doi:10.2337/db07-0767 · Cited by 1,007
Acquired and Inherited Lipodystrophies
Garg, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra025261 · Cited by 941
Divoux, A., Tordjman, J., Lacasa, D., Veyrie, N., Hugol, D., Aissat, A., Basdevant, A., Guerre-Millo, M., Poitou, C., Zucker, J.-D., et al. (2010) · Diabetes · doi:10.2337/db10-0585 · Cited by 621
Cited by
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Tilg, H., Adolph, T. E., Dudek, M., & Knolle, P. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 507
SantaCruz-Calvo, S., Bharath, L., Pugh, G. H., SantaCruz-Calvo, L., Lenin, R., Lutshumba, J., Liu, R., Bachstetter, A., Zhu, B.-B., & Nikolajczyk, B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00575-1 · Cited by 133
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
Sawada, K., Chung, H., Softic, S., Moreno-Fernandez, M. E., & Divanovic, S. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.009 · Cited by 139
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Barrow, F., Khan, S., Wang, H., & Revelo, X. S. (2021) · Hepatology · doi:10.1002/hep.31889 · Cited by 126
TNF superfamily control of tissue remodeling and fibrosis
Steele, H., Cheng, J. H., Willicut, A., Dell, G., Breckenridge, J. E., Culberson, E., Ghastine, A., Tardif, V., & Herro, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219907 · Cited by 91
“Concordantly, in an in-vivo study of nonalcoholic fatty liver disease (NAFLD), high fat diet-fed BAFF mice displayed reduced adipose tissue fibrosis and hepatic steatosis despite a lack of body weight reduction (98).”
Background
Metadata
- Authors
- Nakamura, Y., Abe, M., Kawasaki, K., Miyake, T., Watanabe, T., Yoshida, O., Hirooka, M., Matsuura, B., & Hiasa, Y.
- Affiliations
- Ehime University (JP)
- Corresponding author
- Abe, Masanori
- ORCID
- Venue
- Scientific Reports
- Published
- 2019-01-30
- Volume
- 9
- Issue
- 1
- Pages
- 977-977
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC6353938
- OpenAlex
- W2912238297
- Cited by
- 34
- References
- 35
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 3
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- MEXT | Japan Society for the Promotion of Science (15K09007, 18K07911)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- B-cell activating factor, BAFF, non-alcoholic fatty liver disease, hepatic steatosis, insulin resistance, adipose tissue dysfunction, adipose tissue macrophages, adipose tissue inflammation, adipose tissue fibrosis, de novo lipogenesis, high-fat diet, metabolically healthy obesity, adipokines
- MeSH terms
- Adipose Tissue, Animals, Disease Models, Animal, Fibrosis, Inflammation, Insulin Resistance, Lipids, Liver, Male, Mice, Inbred C57BL, Down-Regulation, Glucose Intolerance, Hepatocytes, Adiposity, B-Cell Activating Factor, Diet, High-Fat, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depletion of B cell‐activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease. https://app.cochat.ai/papers/10.1038/s41598-018-37403-y
- The paper
- Nakamura, Y., Abe, M., Kawasaki, K., Miyake, T., Watanabe, T., Yoshida, O., Hirooka, M., Matsuura, B., & Hiasa, Y. (2019). Depletion of B cell‐activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease. Scientific Reports. https://doi.org/10.1038/s41598-018-37403-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.